Investors Back Creo Medical With $63M In Funding
Executive Summary
Investor confidence in Creo Medical is high. The surgical endoscopy specialist scored nearly £50m to support commercial launch for its electrosurgery device. The AIM-listed firm said the proposed placing, which was "significantly" oversubscribed, was raised through the issue of up to 38.8 million shares.